Research Article
Efficacy and Safety of Lianhuaqingwen Capsules for the Prevention of Coronavirus Disease 2019: A Prospective Open-Label Controlled Trial
Table 9
Comparison of symptoms during the medical observation period.
| Variables | N = 1976 | value | LH group (N = 1101) | Control group (N = 875) |
| Fever | 2 (0.18) | 15 (1.71) | <0.001 | Pharyngodynia | 0 (0.00) | 1 (0.11) | 0.443 | Cough | 1 (0.09) | 0 (0.00) | 1.000 | Expectoration | 0 (0.00) | 1 (0.11) | 0.443 | Diarrhea | 2 (0.18) | 0 (0.00) | 0.506 | Nasal obstruction | 1 (0.09) | 0 (0.00) | 1.000 | Rhinorrhea | 1 (0.09) | 0 (0.00) | 1.000 |
|
|